Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina
By Ernie Mundell HealthDay Reporter
MONDAY, Nov. 11, 2024 -- Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, researchers report.
People with what's known as microvascular disease -- impeded blood flow in tiny blood vessels within the heart -- improved significantly once they got the new stent, according to researchers at the Mayo Clinic in Rochester, Minn.
That's a big turnaround, since "the patients with heart-related microvascular dysfunction in this study had little ability to control their chronic angina, which severely limited their day-to-day activities," noted study senior author Dr. Amir Lerman, a Mayo cardiologist.
His team published its findings Nov. 6 in the Journal of the American College of Cardiology: Cardiovascular Interventions.
According to the American Heart Association, angina is not an illness but a symptom of heart disease.
"Angina is chest pain or discomfort caused when your heart muscle doesn't get enough oxygen-rich blood," the AHA says. "It may feel like pressure or squeezing in your chest. The discomfort also can occur in your shoulders, arms, neck, jaw, abdomen or back. Angina pain may even feel like indigestion."
Recurrent chest pain is a hallmark of microvascular disease, Lerman's team noted. Major arteries may not be blocked but much smaller blood vessels are, and as the heart's blood supply is diminished, angina episodes occur.
Up to two-thirds of people who get a diagnostic coronary angiogram for chest pain do show signs of microvascular disease, the Mayo team said.
Recurrent angina can also be very debilitating, keeping people from the simple activities of daily life. There's not a lot doctors can give patients in this scenario, besides prescribing certain medications or asking them to change to a healthier lifestyle.
Stents are, of course, used in other scenarios to open large arteries. The new stent, with its unique pinched-in-the-middle hourglass design, does seem to help restore blood flow to the tiny blood vessels, Lerman and colleagues found.
In a clinical trial involving 30 patients with microvascular disease and angina, more than three-quarters of patients saw meaningful improvements in their daily lives after receiving the stent, according to the Mayo team.
As they explained, that could mean that a person who couldn't walk around the block or up a flight of stairs without experiencing chest pain before the stent was now able to perform those simple tasks easily, with no discomfort.
"Beyond reductions in chest pain and being able to comfortably handle more physical activity, the majority of patients in the study also showed a connection between the changes in their coronary flow reserve, which is a measure of maximum blood flow, and changes in their quality-of-life responses on the survey," Lerman said in a Mayo news release. "This points to the link between the physiological measurement and angina symptoms."
It's thought that the stent's unique design helps increase "back pressure," on the heart's smaller vessels, to better redistribute blood flow.
Still, the stent wasn't foolproof, and 20% to 30% of patients got no relief from the device, the study also found. Why that is so is the focus of future research, Lerman said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-12 00:00
Read more
- No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
- Standing More During the Day Does Not Cut Cardiovascular Risk
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
- FDA Approves Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara
- FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
- Want to Slowly Cut Down on Dietary Salt? Here's How
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions